|
:: MANAGEMENT TEAM ::
|
| Alexandre
Fouassier
//Engineer in Agronomy,
Master degree in Biochemistry// COO & Director
of Business Development
|
|
|
Alexandre
Fouassier acquired proficiency in molecular biology,
biochemistry and biotechnology within prestigious
research institutes (Harvard Medical School, National
institute for Agronomic Research). He integrated
BioProtein Technologies in 2002 as Business Development
Manager after commercial and marketing studies
at the National Institute of Agronomy of Paris
(INA-PG).
fouassier@bioprotein.com |
| Pierre-Jean
Ripoll
//PhD// R&D
Director,
Molecular Biology Team Manager
|
| |
Pierre-Jean
Ripoll is more than 10 years experienced in molecular
biology and DNA engineering. Prior to join Bioprotein
Technologies, Pierre-Jean has been working for several
years in the biotech industry (Aventis Crop Science
and Biogemma) after post-doctoral experiences in
differents research institutes in US and UK. He
has a strong scientific background in Genetic, Molecular
Biology, Cell Biology, Vectorology and Gene Expression.
Before joining BioProtein Technologies in 2001 as
Scientific Director, Pierre-Jean was involved in
the European project "MapMaize" as well
as in the French National Program "Genoplante".
ripoll@bioprotein.com |
Louis
Marie HOUDEBINE
//Ph.D, Engineer in
Chemistry// Senior Scientific Advisor, co-founder |
| |
Louis-Marie
Houdebine is member of French Commission for Genetics
and Manager of the Animal Gene Study Laboratory
at INRA (Jouy-en-Josas, France). He is recognized
worldwide as one of the leading specialists in the
production of recombinant proteins in the milk of
transgenic animals. He developed a pole of expertise
in the field of vectors carrying genes. |
:::::::::
Back to TOP 
|
|
:: BOARD OF DIRECTORS
::
|
| Jean
LIGNEL
Chairman & CEO
François
DENEUX
Senior Manager, Arthur D. Little, co-fondeur of BioProtein
Technologies.
Marc
PERRET
Investment Director and Partner, Gilde Europe Food and
Agribusiness fund.
Steve
KRAMER
Lawyer at Pavia and Harcourt, representative for IWIC
Investment Group SA.
Leo
VAN WERSCH
CEO Procter & Gamble Pharmaceuticals France, VP
Procter et Gamble Pharmaceuticals Europe
:::::::::
Back to TOP
|
|
|
:::::
PEOPLE ::::: 
